FAM161A 抗体 (AA 301-400) (AbBy Fluor® 488)
-
- 抗原 See all FAM161A 抗体
- FAM161A (Family with Sequence Similarity 161, Member A (FAM161A))
-
抗原表位
- AA 301-400
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This FAM161A antibody is conjugated to AbBy Fluor® 488
-
应用范围
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- 交叉反应
- 人
- 预测反应
- Mouse,Rat,Dog
- 纯化方法
- Purified by Protein A.
- 免疫原
- KLH conjugated synthetic peptide derived from human FAM161A
- 亚型
- IgG
- Top Product
- Discover our top product FAM161A Primary Antibody
-
-
- 应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 1 μg/μL
- 缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 储存条件
- -20 °C
- 储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- 有效期
- 12 months
-
- 抗原
- FAM161A (Family with Sequence Similarity 161, Member A (FAM161A))
- 别名
- FAM161A (FAM161A 产品)
- 别名
- RP28 antibody, 4930430E16Rik antibody, RGD1304999 antibody, family with sequence similarity 161 member A antibody, family with sequence similarity 161, member A antibody, FAM161A antibody, Fam161a antibody
- 背景
-
Synonyms: F161A_HUMAN, Fam161a, Family with sequence similarity 161, member A, FLJ13305, Hypothetical protein LOC84140, MGC129982, MGC129983, OTTHUMP00000201353, Protein FAM161A.
Background: Isoform 1 and isoform 3 are widely expressed with highest levels in retina and testis, with isoform 1 being the mot abundant in all tissues tested.Involvement in disease:Defects in FAM161A are the cause of retinitis pigmentosa type 28 (RP28) . A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well.
-